Skip to content

S. 1250 · 118th Congress (2023–2025)

Drug-price Transparency for Consumers Act of 2023

Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023

This bill requires consumer advertisements for drugs and biologicals to include certain price information if the drug or biological is (1) covered under Medicare or Medicaid, and (2) required to include a risk summary under current law. The requirement does not apply to advertisements for drugs or biologicals with a wholesale cost of less than $35 for a one-month supply.

Each violation of this requirement is subject to a civil penalty of not more than $100,000.


Show official title

A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 1250’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Richard J. Durbin (D-IL)
Cosponsors
8 cosponsors

6 original · 2 later

3 R · 4 D · 1 I

  1. Sen. Tammy Baldwin (D-WI)· Original · Apr 20, 2023
  2. Sen. Richard Blumenthal (D-CT)· Original · Apr 20, 2023
  3. Sen. Mike Braun (R-IN)· Original · Apr 20, 2023
  4. Sen. Chuck Grassley (R-IA)· Original · Apr 20, 2023
  5. Sen. Angus S. King Jr. (I-ME)· Original · Apr 20, 2023
  6. Sen. J. D. Vance (R-OH)· Original · Apr 20, 2023
  7. Sen. Sherrod Brown (D-OH)· Later · Jul 12, 2023
  8. Sen. Tina Smith (D-MN)· Later · Sep 7, 2023
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Civil actions and liability
  • Department of Health and Human Services
  • Health care costs and insurance
  • Marketing and advertising
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Congressional Record S1297; text: CR S1297-1298; S1297; text: CR S1297-1298

    Read twice and referred to the Committee on Finance.

    Sources
  3. Expired

    Introduced → Referred to Senate Finance → No further action before the 118th Congress ended.

Committees

  1. SenateFinanceReferred Apr 20, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Drug-price Transparency for Consumers Act of 2023

    Display title, Short title · Introduced in Senate

  2. A bill to amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.

    Official title · Introduced in Senate